Referências

1. Admiraal, R., Lindemans, C.A., van Kesteren, C., Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation (2016) Blood, 128, pp. 2734-41
2. Admiraal, R., van Kesteren, C., Jol-van der Zijde, C.M., Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis (2015) Lancet Haematol, 2
3. Atsuta, Y., Morishima, Y., Suzuki, R., Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia (2012) Biol Blood Marrow Transplant, 18, pp. 780-7
4. Barker, J.N., Kurtzberg, J., Ballen, K., Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies (2017) Biol Blood Marrow Transplant, 23, pp. 882-96
5. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Miller, J.S., Verfaillie, C.M., Wagner, J.E., Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy (2005) Blood, 105, pp. 1343-7
6. Brunstein, C.G., Barker, J.N., Weisdorf, D.J., Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease (2007) Blood, 110, pp. 3064-70
7. Brunstein, C.G., Fuchs, E.J., Carter, S.L., Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts (2011) Blood, 118, pp. 282-8
8. Brunstein, C.G., Gutman, J.A., Weisdorf, D.J., Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood (2010) Blood, 116, pp. 4693-9
9. Chiesa, R., Gilmour, K., Qasim, W., Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant (2012) Br J Haematol, 156, pp. 656-66
10. Eapen, M., Rubinstein, P., Zhang, M.J., Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study (2007) Lancet, 369, pp. 1947-54
11. Hough, R., Danby, R., Russell, N., Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols (2016) Br J Haematol, 172, pp. 360-70
12. Mehta, R.S., Dave, H., Bollard, C.M., Engineering cord blood to improve engraftment after cord blood transplant (2017) Stem Cell Investig, 4, p. 41
13. Michel, G., Galambrun, C., Sirvent, A., Single-vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome (2016) Blood, 127, pp. 3450-7
14. Milano, F., Gooley, T., Wood, B., Cord-blood transplantation in patients with minimal residual disease (2016) N Engl J Med, 375, pp. 944-53
15. Ponce, D.M., Eapen, M., Sparapani, R., In vivo T cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children (2015) Biol Blood Marrow Transplant, 21, pp. 2173-9
16. Ross, K., Gutman, J., (2017) Cord blood transplantations, , New York: Springer
17. Ruggeri, A., Labopin, M., Sanz, G., Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia (2015) Leukemia, 29, pp. 1891-900
18. Ruggeri, A., Sanz, G., Bittencourt, H., Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT (2014) Leukemia, 28, pp. 779-86
19. Sanz, J., Boluda, J.C.H., Martín, C., Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloabla-tive conditioning regimen (2012) Bone Marrow Transplant, 47, pp. 1287-93
20. Sanz, J., Kwon, M., Bautista, G., Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia (2017) Blood Adv, 1, p. 1047
21. Sanz, J., Wagner, J.E., Sanz, M.A., Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms (2013) Biol Blood Marrow Transplant, 19, pp. 1725-30
22. Scaradavou, A., Brunstein, C.G., Eapen, M., Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia (2013) Blood, 121, pp. 752-8
23. Wagner, J.E., Eapen, M., Carter, S., One-unit versus two-unit cord-blood transplantation for hematologic cancers (2014) N Engl J Med, 371, pp. 1685-94